Skip to Main Content

Author Details

Richard L Wahl
Mallinckrodt Institute of Radiology, Washington University in St. Louis
1983
550
89
PMIDPaper TitleJournal TitlePublished Year
37292467Joint regional uptake quantification of Thorium-227 and Radium-223 using a multiple-energy-window projection-domain quantitative SPECT method.ArXiv2024
35981897Cure of Micrometastatic B-Cell Lymphoma in a SCID Mouse Model Using <sup>213</sup>Bi-Anti-CD20 Monoclonal Antibody.J Nucl Med2023
37620051Ethical Considerations for Artificial Intelligence in Medical Imaging: Deployment and Governance.J Nucl Med2023
37652539Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial).J Nucl Med2023
37827839Ethical Considerations for Artificial Intelligence in Medical Imaging: Data Collection, Development, and Evaluation.J Nucl Med2023
37540134Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations.Radiol Imaging Cancer2023
35772963Diagnostic Accuracy of <sup>99m</sup>Tc-Sestamibi SPECT/CT for Characterization of Solid Renal Masses.J Nucl Med2023
37024304Cure of Disseminated Human Lymphoma with [<sup>225</sup>Ac]Ac-Ofatumumab in a Preclinical Model.J Nucl Med2023
36945690Need for Objective Task-based Evaluation of Deep Learning-Based Denoising Methods: A Study in the Context of Myocardial Perfusion SPECT.ArXiv2023
37385671Reply: Radiopharmaceutical Extravasations CanHave Consequences.J Nucl Med2023
37142300Evaluation of Candidate Theranostics for <sup>227</sup>Th/<sup>89</sup>Zr Paired Radioimmunotherapy of Lymphoma.J Nucl Med2023
37010001Need for objective task-based evaluation of deep learning-based denoising methods: A study in the context of myocardial perfusion SPECT.Med Phys2023
37201111A Projection-Domain Low-Count Quantitative SPECT Method for <i>α</i>-Particle-Emitting Radiopharmaceutical Therapy.IEEE Trans Radiat Plasma Med Sci2023
36995946FDG PET/CT-based Response Assessment in Malignancies.Radiographics2023
36961012Animal Models and Their Role in Imaging-Assisted Co-Clinical Trials.Tomography2023
36858729Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop.Lancet Oncol2023
36522184Artificial Intelligence in Nuclear Medicine: Opportunities, Challenges, and Responsibilities Toward a Trustworthy Ecosystem.J Nucl Med2023
36149725Radiochemical Quality Control Methods for Radium-223 and Thorium-227 Radiotherapies.Cancer Biother Radiopharm2023
36137760The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification.J Nucl Med2023
36357179Cure of Disseminated Human Lymphoma with [<sup>177</sup>Lu]Lu-Ofatumumab in a Preclinical Model.J Nucl Med2023
36265907Adverse Clinical Events at the Injection Site Are Exceedingly Rare After Reported Radiopharmaceutical Extravasation in Patients Undergoing <sup>99m</sup>Tc-MDP Whole-Body Bone Scintigraphy: A 12-Year Experience.J Nucl Med2023
36229184Progression or Response: New Liver Lesions in a Patient with Responding Hodgkin Lymphoma.J Nucl Med2023
34328530Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer.Eur J Nucl Med Mol Imaging2022
35649663SNMMI Leadership Update: Putting Patients First: A Year in Review.J Nucl Med2022
35403861Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre.Eur J Nucl Med Mol Imaging2022
35376991Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0.Eur J Nucl Med Mol Imaging2022
35393347Brown Adipose Tissue: A Protective Mechanism Against "Preprediabetes"?J Nucl Med2022
35487566SNMMI Leadership Update: SNMMI's Role in the Nuclear Medicine Renaissance.J Nucl Med2022
35450957Joint EANM, SNMMI, and IAEA Enabling Guide: How to Set up a Theranostics Center.J Nucl Med2022
35618476Nuclear Medicine and Artificial Intelligence: Best Practices for Evaluation (the RELAINCE Guidelines).J Nucl Med2022
36539908Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [<sup>18</sup>F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors.Cancer Imaging2022
36457510Automated lesion detection of breast cancer in [<sup>18</sup>F] FDG PET/CT using a novel AI-Based workflow.Front Oncol2022
35101933SNMMI to Host Summits on Artificial Intelligence and Patient Access.J Nucl Med2022
34980671Ensuring Quality and Safety in Nuclear Medicine Imaging and Therapy.J Nucl Med2022
34996594Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting.Semin Nucl Med2022
35232889SNMMI Leadership Update: Call the Nuclear Oncologist.J Nucl Med2022
34550428Correction to: Coâ¿¿clinical FDGâ¿¿PET radiomic signature in predicting response to neoadjuvant chemotherapy in tripleâ¿¿negative breast cancer.Eur J Nucl Med Mol Imaging2022
34520350Machine Learning-Based Noninvasive Quantification of Single-Imaging Session Dual-Tracer <sup>18</sup>F-FDG and <sup>68</sup>Ga-DOTATATE Dynamic PET-CT in Oncology.IEEE Trans Med Imaging2022
34740952Nuclear Medicine and Artificial Intelligence: Best Practices for Algorithm Development.J Nucl Med2022
34413144Detection of Additional Primary Neoplasms on <sup>18</sup>F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer.J Nucl Med2022
33008931Repeatability of <sup>18</sup>F-FDG PET Radiomic Features in Cervical Cancer.J Nucl Med2021
33830414Bioluminescent Tumor Signal Is Mouse Strain and Pelt Color Dependent: Experience in a Disseminated Lymphoma Model.Mol Imaging Biol2021
33829361Prospective Within-Patient Assessment of the Impact of an Unlabeled Octreotide Pre-dose on the Biodistribution and Tumor Uptake of <sup>68</sup>Ga DOTATOC as Assessed by Dynamic Whole-body PET in Patients with Neuroendocrine Tumors: Implications for Diagnosis and Therapy.Mol Imaging Biol2021
33893189At Last, <sup>18</sup>F-FDG for Inflammation and Infection!J Nucl Med2021
33837069Improved Radium-223 Therapy with Combination Epithelial Sodium Channel Blockade.J Nucl Med2021
33580383Quantitation of cancer treatment response by 2-[<sup>18</sup>F]FDG PET/CT: multi-center assessment of measurement variability using AUTO-PERCISTâ¿¢.EJNMMI Res2021
34857623Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice.J Nucl Med2021
34857618Radiopharmaceutical Dosimetry for Cancer Therapy: From Theory to Practice.J Nucl Med2021
34857619Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns.J Nucl Med2021
34204102Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (<sup>111</sup>In)/Yttrium 90 (<sup>90</sup>Y) Ibritumomab Tiuxetan (Zevalin<sup>®</sup>) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels.Cancers (Basel)2021
  • 1 - 50 of 550

Recommended Authors

Randy Yeh
Department of Radiology Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 3
Jeremie Calais
university of california los angeles
Career Start Year 2014
Number of shared co-authors 9
Milan Grkovski
Memorial Sloan Kettering Cancer Center
Career Start Year 2012
Number of shared co-authors 5
Zhifang Wu
The First Hospital of Shanxi Medical University
Career Start Year 2009
Number of shared co-authors 1
Vincenzo Paolillo
UT MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Pedram Heidari
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 3
Spencer C Behr
University of California san francisco
Career Start Year 2007
Number of shared co-authors 4
Youngho Seo
University of California san francisco
Career Start Year 2005
Number of shared co-authors 4
Guido Davidzon
Stanford University
Career Start Year 2005
Number of shared co-authors 1
Pardeep Kumar
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year 2005
Number of shared co-authors 1
Chaya S Moskowitz
Memorial Sloan Kettering Cancer Center.
Career Start Year 2002
Number of shared co-authors 3
Zhaohui Zhu
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 2000
Number of shared co-authors 1
Chuong Bui
Nepean Hospital
Career Start Year 1999
Number of shared co-authors 0
Lance T Hall
University of Wisconsin Hospitals and Clinics
Career Start Year 1998
Number of shared co-authors 0
Winnie Wing-Chuen Lam
Singapore General Hospital
Career Start Year 1997
Number of shared co-authors 0
Gang Niu
The First Affiliated Hospital of Xi'an Jiaotong University
Career Start Year 1997
Number of shared co-authors 1
Nobuyuki Kosaka
University of Fukui.
Career Start Year 1997
Number of shared co-authors 2
Carolien P Schr??der
University of Groningen, University Medical Center Groningen
Career Start Year 1995
Number of shared co-authors 2
Leo G Flores
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Baixuan Xu
First Medical Center, Chinese PLA General Hospital
Career Start Year 1994
Number of shared co-authors 1
Frank P DiFilippo
Cleveland Clinic
Career Start Year 1992
Number of shared co-authors 3
Juri G Gelovani
Karmanos Cancer Institute (KCI), Wayne State University
Career Start Year 1990
Number of shared co-authors 3
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 6
Javier E Villanueva-Meyer
University of California san francisco
Career Start Year 1986
Number of shared co-authors 7
Curtis B Caldwell
Sunnybrook Research Institute
Career Start Year 1986
Number of shared co-authors 6
Edwin L Palmer
Massachusetts General Hospital
Career Start Year 1984
Number of shared co-authors 0
Jiahe Tian
First Medical Center of Chinese PLA General Hospital
Career Start Year 1982
Number of shared co-authors 1
James R Bading
City of Hope National Medical Center
Career Start Year 1982
Number of shared co-authors 1
Chaitanya Divgi
Columbia University Medical Center Kreitchman PET Center
Career Start Year 1981
Number of shared co-authors 5
Peter S Conti
Keck School of Medicine of USC
Career Start Year 1971
Number of shared co-authors 2

Collaborators

Arman Rahmim
BC Cancer Research Institute, University of British Columbia
Co-authored papers 12
John J Sunderland
University of Iowa
Co-authored papers 11
Vered Stearns
Co-authored papers 11
William H Beierwaltes
Wayne State University School of Medicine
Co-authored papers 10
Stewart Kroll
La Jolla Pharmaceutical Company
Co-authored papers 10
Abhinav K Jha
Washington University in St. Louis
Co-authored papers 9
Antonio C Wolff
Co-authored papers 8
Herbert Barton Grossman
University of Texas MD Anderson Cancer Center
Co-authored papers 8
Ronald Boellaard
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Co-authored papers 7
Babak Saboury
Clinical Center
Co-authored papers 6
Neeta Pandit-Taskar
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Anna Maria Storniolo
Co-authored papers 5
Wayne M Koch
Johns Hopkins University School of Medicine
Co-authored papers 5
Shunqiang Li
Co-authored papers 4
Richard D Schulick
University of Colorado School of Medicine
Co-authored papers 4
Minetta C Liu
Co-authored papers 4
Eric P Winer
Dana-Farber Cancer Institute
Co-authored papers 4
Brian O'Rourke
Co-authored papers 4
Sven Zuehlsdorff
Siemens Medical Solutions USA, Inc.
Co-authored papers 4
Lisa A Carey
Co-authored papers 4
Daniel L Rubin
Stanford University.
Co-authored papers 4
Ir??ne Buvat
Institut Curie, PSL Research University, University Paris Saclay, Inserm LITO
Co-authored papers 3
Ralph E Coleman
Duke University School of Medicine
Co-authored papers 3
Peter J H Scott
University of Michigan Medical School ann arbor
Co-authored papers 3
Richard T Kloos
Veracyte Inc.
Co-authored papers 3
George F Tidmarsh
La Jolla Pharmaceutical Company
Co-authored papers 3
Tyler J Bradshaw
University of Wisconsin-Madison
Co-authored papers 3
Charles Steenbergen
Co-authored papers 3
Richard J Jones
Sidney Kimmel Cancer Center, Johns Hopkins University
Co-authored papers 3
Mothaffar F Rimawi
Co-authored papers 3
Release 1.2